天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

benzyl 4-(2-tert-butoxy-2-oxoethyl)piperazine-1-carboxylate

benzyl 4-(2-tert-butoxy-2-oxoethyl)piperazine-1-carboxylate Struktur
112275-51-1
CAS-Nr.
112275-51-1
Englisch Name:
benzyl 4-(2-tert-butoxy-2-oxoethyl)piperazine-1-carboxylate
Synonyma:
NXTOTSQOMBNWFA-UHFFFAOYSA-N;benzyl 4-(2-tert-butoxy-2-oxoethyl)piperazine-1-carboxylate;1-Piperazineacetic acid, 4-[(phenylmethoxy)carbonyl]-, 1,1-dimethylethyl ester
CBNumber:
CB52627589
Summenformel:
C18H26N2O4
Molgewicht:
334.41
MOL-Datei:
112275-51-1.mol

benzyl 4-(2-tert-butoxy-2-oxoethyl)piperazine-1-carboxylate Eigenschaften

Siedepunkt:
439.8±45.0 °C(Predicted)
Dichte
1.137±0.06 g/cm3(Predicted)
pka
4.67±0.10(Predicted)

Sicherheit

benzyl 4-(2-tert-butoxy-2-oxoethyl)piperazine-1-carboxylate Chemische Eigenschaften,Einsatz,Produktion Methoden

benzyl 4-(2-tert-butoxy-2-oxoethyl)piperazine-1-carboxylate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

benzyl 4-(2-tert-butoxy-2-oxoethyl)piperazine-1-carboxylate Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 8)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Chengdu Firster Pharmaceutical Co., Ltd. 028-87078428 028-87074958
 chengzhenyong@cdfirster.com China 2602 60
Changzhou Kechem Bio-Scientific Co., LTD. 0519-68985668 13685222090
 sales@kechem.cn China 26028 58
Shanghai Xiushi Biomedical Co., LTD 15021598081,571034478; 15021598081
 product001@xiushipharm.com China 4748 58
Hebei Int'en Pharmaceutical Technology Co., Ltd 18932921510
 jyxia@int-nph.com China 2990 58
Shanghai Renruida Biomedical Technology Co., Ltd 17316456674 15316859367
 1510693667@qq.com China 3000 58
Aikon International Limited 025-58851090 13408877820
 2850281427@qq.com China 10000 58
  • benzyl 4-(2-tert-butoxy-2-oxoethyl)piperazine-1-carboxylate
  • 1-Piperazineacetic acid, 4-[(phenylmethoxy)carbonyl]-, 1,1-dimethylethyl ester
  • NXTOTSQOMBNWFA-UHFFFAOYSA-N
  • 112275-51-1
Copyright 2019 ? ChemicalBook. All rights reserved